shortagewatch

Home / Cancer and immune system / Epirubicin

ATC L01DB03 · Antineoplastic Agents

Epirubicin shortage

As of 31 Oct 2026, Epirubicin has a reported shortage in 4 of the 5 countries we track (Italy, Spain, Austria, Belgium), covering 11 products.

Countries4/5
Products11packs or presentations
Short since4 Nov 20215.0 years ago
Earliest return27 Feb 2027company estimate
No return date8products
Main reasonManufacturing problem
GermanyNo reported shortageItaly6 packs shortSpain1 pack shortAustria2 packs shortBelgium2 packs short

Timeline

ItalySpainAustriaBelgium
2022202320242025202620282029EPIRUBICINA AHCLEPIRUBICINA AHCLEPIRUBICINA AHCLEPIRUBICINA AHCLFARMORUBICINA 2 mg/ml SOLUCION INYECTABLE Y FARMORUBICINA 2 mg/ml SOLUCION INYECTABLE Y PARA PERFUSION , 1 vial de 25 mlFarmorubicin 200 mg Stechampulle, 1 StückFarmorubicin 200 mg Stechampulle, 1 StückFarmorubicin 50 mg Stechampulle, 1 StückFarmorubicin 50 mg Stechampulle, 1 StückEpirubicin Eugia 2 mg/ml inj. sol. i.v. vialEpirubicin Eugia 2 mg/ml inj. sol. i.v. vial 100 mlEpirubicin Eugia 2 mg/ml inj. sol. i.v. vialEpirubicin Eugia 2 mg/ml inj. sol. i.v. vial 25 mltoday

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Affected products

CountryProductHolderSinceExpected backReason
ITEPIRUBICINA AHCLACCORD HEALTHCARE, S.L.U.5 Jun 2026not givenManufacturing problem
Problemi produttivi
ITEPIRUBICINA AHCLACCORD HEALTHCARE, S.L.U.31 Oct 2026not givenCommercial decision or withdrawal
Motivi commerciali
ITFARMORUBICINA announcedPFIZER ITALIA S.R.L.16 Nov 2026not givenManufacturing problem
Problemi produttivi
ITEPIRUBICINA AHCL announcedACCORD HEALTHCARE, S.L.U.25 Nov 2026not givenManufacturing problem
Problemi produttivi
ITFARMORUBICINA announcedPFIZER ITALIA S.R.L.1 Dec 2026not givenManufacturing problem
Problemi produttivi
ITFARMORUBICINA announcedPFIZER ITALIA S.R.L.12 Jan 2027not givenManufacturing problem
Problemi produttivi
ESFARMORUBICINA 2 mg/ml SOLUCION INYECTABLE Y PARA PERFUSION , 1 vial de 25 mlPfizer S.L.20 Aug 202530 Dec 2028Not stated
ATFarmorubicin 200 mg Stechampulle, 1 StückPfizer Corporation Austria Ges.m.b.H.4 Nov 2021not givenQuality problem or recall
Qualitätsprobleme der Bulkware
ATFarmorubicin 50 mg Stechampulle, 1 StückPfizer Corporation Austria Ges.m.b.H.4 Feb 2022not givenQuality problem or recall
Qualitätsprobleme des Fertigproduktes
BEEpirubicin Eugia 2 mg/ml inj. sol. i.v. vial 100 mlEugia Pharma (Malta)17 Feb 202327 Feb 2027Other
Other reason
BEEpirubicin Eugia 2 mg/ml inj. sol. i.v. vial 25 mlEugia Pharma (Malta)17 Feb 202327 Mar 2027Other
Other reason

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.

Related medicines also in short supply

Doxorubicin Idarubicin Mitoxantrone